A Study of LY2875358 in Japanese Participants With Advanced Cancer

Clinical trial NCT01602289 · COMPLETED

Trial details

NCT number: NCT01602289
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Lymphoma Carcinoma, Non-Small-Cell Lung

Start date: 2012-06-01
Primary completion: 2014-08-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.